Ophthalmic compositions for treating ocular hypertension
US7547720B2 · kind B2 · utility
2Cited by
10References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2006 |
| Grant date | Jun 16, 2009 |
| Priority date | — |
| Expiry date | Dec 27, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraocular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.